Eli Lilly and Company (LLY): Among the Best Stocks to Buy While the Market Is Down
Summary
On April 20, Reuters reported that Eli Lilly and Company (NYSE:LLY) is buying Kelonia Therapeutics in a deal valued at up to $7 billion.
Description
On April 20, Reuters reported that Eli Lilly and Company (NYSE:LLY) is buying Kelonia Therapeutics in a deal valued at up to $7 billion.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source